Volume 24, Issue 5 (September-October 2025)
Payesh 2025, 24(5): 743-746 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rahmati F, Farzanehpour M. Marburg Virus Disease: Is a Threatening Virus on the way?. Payesh 2025; 24 (5) :743-746
URL: http://payeshjournal.ir/article-1-2212-en.html
URL: http://payeshjournal.ir/article-1-2212-en.html
1- Health Research Center, Lifestyle Research Institute, Baqiyatullah University of Medical Sciences (AJ), Tehran, Iran
2- Applied Virology Research Center, Baqiyatullah University of Medical Sciences (AJ), Tehran, Iran
2- Applied Virology Research Center, Baqiyatullah University of Medical Sciences (AJ), Tehran, Iran
Abstract: (34 Views)
Dear Editor,
Marburg virus (MARV) is a highly lethal virus that causes severe hemorrhagic fever with a high mortality rate. Marburg virus disease is common between humans and livestock (animals) and the reservoir is the Egyptian fruit bat (Rousettus aegyptiacus).
In African countries, Egyptian fruit bats have been reported in caves and mines as a reservoir of disease and the agent of human transmission after the initial joint transmission between humans and livestock from an infected animal to humans, then transmission is enhanced through close human-to-human contact. to be Currently, there are no approved vaccines or treatments to diagnose and treat patients. The most reliable treatment method is supportive and monitoring. MARV is ethically challenging because without field efficacy studies, researchers must rely on animal models of MARV. Emerging viral infectious diseases, especially those caused by bats (eg, coronavirus and Ebola virus), significantly affect public health and the global economy. A deadly virus like Ebola, MARV is highly contagious and will spread rapidly during an MVD outbreak, causing health and social problems. Key protective measures must be taken immediately to prevent this situation.
Marburg virus (MARV) is a highly lethal virus that causes severe hemorrhagic fever with a high mortality rate. Marburg virus disease is common between humans and livestock (animals) and the reservoir is the Egyptian fruit bat (Rousettus aegyptiacus).
In African countries, Egyptian fruit bats have been reported in caves and mines as a reservoir of disease and the agent of human transmission after the initial joint transmission between humans and livestock from an infected animal to humans, then transmission is enhanced through close human-to-human contact. to be Currently, there are no approved vaccines or treatments to diagnose and treat patients. The most reliable treatment method is supportive and monitoring. MARV is ethically challenging because without field efficacy studies, researchers must rely on animal models of MARV. Emerging viral infectious diseases, especially those caused by bats (eg, coronavirus and Ebola virus), significantly affect public health and the global economy. A deadly virus like Ebola, MARV is highly contagious and will spread rapidly during an MVD outbreak, causing health and social problems. Key protective measures must be taken immediately to prevent this situation.
Subject:
Epidemiologhy
Received: 2023/07/9 | Accepted: 2023/07/16 | ePublished ahead of print: 2025/11/9 | Published: 2025/11/9
Received: 2023/07/9 | Accepted: 2023/07/16 | ePublished ahead of print: 2025/11/9 | Published: 2025/11/9
References
1. Amman BR, Bird BH, Bakarr IA, Bangura J, Schuh AJ, Johnny J, et al.Isolation of Angola-like Marburg virus from Egyptian rousette bats from West Africa. Nature Communications 2020; 11:510 [DOI:10.1038/s41467-020-14327-8]
2. King LB, West BR, Schendel SL, Saphire EO. The structural basis for filovirus neutralization by monoclonal antibodies. Current Opinion in Immunology 2018; 53:196-202 [DOI:10.1016/j.coi.2018.05.001]
3. Siegert R, Shu H-L, Slenczka W. Isolierung und Identifizierung des "Marburg-Virus". DMW-Deutsche Medizinische Wochenschrift 1968; 93:604-612 [DOI:10.1055/s-0028-1105103]
4. Slenczka W, Klenk HD. Forty years of Marburg virus. The Journal of Infectious Diseases 2007; 196:S131-S135 [DOI:10.1086/520551]
5. Nikiforov V, IuI T, Kalinin P, Akinfeeva L, Katkova L, Barmin V, et al. A case of a laboratory infection with Marburg fever. Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii 1994:104-10
6. Towner JS, Amman BR, Sealy TK, Carroll SAR, Comer JA, Kemp A, et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathogens 2009; 5:e1000536 [DOI:10.1371/journal.ppat.1000536]
7. Pigott DM, Golding N, Mylne A, Huang Z, Weiss DJ, Brady OJ, et al. Mapping the zoonotic niche of Marburg virus disease in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 2015; 109:366-378 [DOI:10.1093/trstmh/trv024]
8. Pavlin BI. Calculation of incubation period and serial interval from multiple outbreaks of Marburg virus disease. BMC Research Notes 2014; 7:1-6 [DOI:10.1186/1756-0500-7-906]
9. Timen A, Koopmans MP, Vossen AC, van Doornum GJ, Günther S, Van den Berkmortel F, et al. Response to imported case of Marburg hemorrhagic fever, the Netherlands. Emerging Infectious Diseases 2009; 15:1171 [DOI:10.3201/eid1508.090015]
10. Marzi A, Jankeel A, Menicucci AR, Callison J, O'Donnell KL, Feldmann F, et al. Single dose of a VSV-based vaccine rapidly protects macaques from Marburg virus disease. Frontiers in Immunology 2021; 12:774026 [DOI:10.3389/fimmu.2021.774026]
11. Barry H, Mutua G, Kibuuka H, Anywaine Z, Sirima SB, Meda N, et al.Safety and immunogenicity of 2-dose heterologous Ad26. ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa. PLoS Medicine 2021; 18:e1003813 [DOI:10.1371/journal.pmed.1003813]
12. Cross RW, Bornholdt ZA, Prasad AN, Borisevich V, Agans KN, Deer DJ, et al.Combination therapy protects macaques against advanced Marburg virus disease. Nature Communications 2021; 12:1891 [DOI:10.1038/s41467-021-22132-0]
13. Fujita N, Miller A, Miller G, Gershman K, Gallagher N, Marano N, et al. Imported case of Marburg hemorrhagic fever-Colorado, 2008. Morbidity and Mortality Weekly Report 2009; 58:1377-1381
Send email to the article author
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |